About MIG Fonds
MIG Fonds is a venture capital firm founded in 2004. It is primarily based out of Munchen, Germany. As of Apr 2026, MIG Fonds has invested in 43 companies. It primarily invests in Series A round in Germany based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of mbiomics Overall, MIG Fonds portfolio has seen 1 unicorn, 3 IPOs and 6 acquisitions including key companies like IQM, BioNTech and Immatics. A lot of funds co-invest with MIG Fonds, with names like BayBG sharing a substantial percentage of its portfolio. MIG Fonds has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Rounds of Entry
Series A, Seed & 5 more
Portfolio Acquisitions
Portfolio Unicorns
MIG Fonds' List of Top Investments
MIG Fonds has a portfolio of 43 companies, one of which is a Unicorn. Their most notable investments are in LXP Group and NavVis.Their portfolio spans across Germany, France, Austria and 6 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 16 other sectors, across stages such as Series A, Seed and 5 more. Here is the list of top investments by MIG Fonds:1. IQM
Developer of superconducting quantum computers. Its features include quantum processors with on-chip components that increase QPU clock speed for error correction, as well as application-specific processors and quantum operations.
Key facts about IQM
- Founded Year: 2018
- Location: Espoo (Finland)
- Annual Revenue: €10M - €50M as on Dec 31, 2025
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $600M
- Employee Count: 399 as on May 31, 2026
- Investors: Ten Eleven Ventures, Samsara BioCapital and 27 Others
- Latest Funding Round: Conventional Debt, Mar 30, 2026, $*****
- Highlight: Editors' Pick
2. BioNTech
Developer of immunotherapeutics for the treatment of cancer and other diseases. Its oncology drug pipeline contains several classes of drugs which include mRNA treatments, modified cell therapies, antibodies, and small molecule immunomodulators that have been optimised for distinct modes of action, high precision targeting, potency, and efficacy.
Key facts about BioNTech
- Founded Year: 2008
- Location: Mainz (Germany)
- Stage: Public
- Total Funding till date: $861M
- Employee Count: 5,188 as on Aug 31, 2026
- Investors: Fidelity Investments, Janus Henderson Investors and 28 Others
- Latest Funding Round: Post IPO, Apr 14, 2022, $*****
- Highlight: Public
3. Immatics
Developer of T -cell-based immunotherapies for the treatment of cancer. The company has propriety platform XPRESIDENT is involved in identifying and validating antigens specific to cancer cells and subsequently develops adoptive cell therapies and bispecific TCRs for treating cancer. IMA101, using its proprietary ACTolog approach, which is T-cell products generated from peripheral blood cells with defined target selectivity.
Key facts about Immatics
- Founded Year: 2000
- Location: Tubingen (Germany)
- Stage: Public
- Total Funding till date: $236M
- Employee Count: 652 as on Aug 31, 2026
- Investors: Amgen Business Development, Timefolio Capital and 19 Others
- Latest Funding Round: Post IPO, Jul 24, 2023, $*****
- Highlight: Public
4. AMSilk
Manufacturer of biotech silk protein materials for various industry applications. The company utilizes protein design and precision fermentation to produce materials with superior performance and lower environmental impact. These materials are available in formulations including fibers, yarns, hydrogels, and silk powder. The company provides these materials to enhance consumer lives across multiple industries.
Key facts about AMSilk
- Founded Year: 2008
- Location: Neuried (Germany)
- Annual Revenue: €0 - €1M as on Dec 31, 2024
- Stage: Series D
- Total Funding till date: $130M
- Employee Count: 78 as on Aug 31, 2026
- Investors: Cargill, Novo Holdings and 9 Others
- Latest Funding Round: Series D, Sep 09, 2025, $*****
- Highlight: Editors' Pick
5. Mimi
Provider of personalized audio solutions and hearing tests. It offers sound personalization technology adaptable to individual hearing profiles, enhancing audio experiences across headphones, televisions, and speakers. It also provides a hearing test app, generating a hearing profile used to create customized audio presets. It aims to restore missing audio details, enhance clarity, and eliminate the need for high volume settings. The resulting data contributes to a database of hearing profiles, informing research on hearing trends.
Key facts about Mimi
- Founded Year: 2014
- Location: Berlin (Germany)
- Stage: Series B
- Total Funding till date: $25.4M
- Employee Count: 43 as on Aug 31, 2026
- Investors: Atlantic Labs, MIG Fonds and 16 Others
- Latest Funding Round: Series B, Dec 15, 2021, $*****
- Highlight: Editors' Pick
MIG Fonds' Year-on-Year Investment Trends
MIG Fonds has invested in 43 companies over the last 21 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment, while as of Apr 2026, it has made 1 investment in this year. Its most recent first time investment was in Astra and most recent follow-on round was in mbiomics.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 1 | 0 | 1 |
2024 | 0 | 0 | 0 |
2023 | 2 | 0 | 2 |
2022 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 |
2020 | 3 | 1 | 4 |
2019 | 2 | 1 | 3 |
2018 | 0 | 1 | 1 |
2017 | 0 | 2 | 2 |
MIG Fonds' Investments by Stage
MIG Fonds has made 8 investments in Series A stage with an average round size of $10.9M, 4 investments in Seed stage with an average round size of $4.24M and 3 investments in Series B stage with an average round size of $10.3M.Stage of entry | No. of Investments |
|---|---|
Series A | 8 |
Seed | 4 |
Series B | 3 |
Series D | 3 |
Series C | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
MIG Fonds' Investments by Sector
MIG Fonds has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, High Tech, Sustainability Tech and Environment Tech. Notably, it has invested in 37 Enterprise (B2B) companies, 35 Tech companies, 16 Software companies and at least 13 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Enterprise Applications | 9 |
Life Sciences | 9 |
High Tech | 8 |
Sustainability Tech | 7 |
Environment Tech | 4 |
Others | 15 |
Note: We have considered here, only first round of investments
MIG Fonds' Investments by Geography
MIG Fonds has made most investments in Germany (20), followed by Austria where it has made 1 investment.Country | No. of Investments |
|---|---|
Germany | 20 |
Austria | 1 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
MIG Fonds' recent investments
MIG Fonds has made 1 investments in 2026 so far - mbiomics.Here are the most recent investments by MIG Fonds:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 28, 2026 | Germany | Series A | 1451 | ||
Jul 24, 2025 | Switzerland | Seed | 5654 | [+3] | |
Mar 23, 2023 | Germany | Series A | 8498 | [+1] | |
Feb 08, 2023 | Germany | Series D | 6870 | [+1] | |
Dec 14, 2020 | Germany | Series A | 8178 |
Unicorns in MIG Fonds' Portfolio
MIG Fonds has 1 unicorn in its portfolio - IQM. The most recent unicorn in their portfolio is IQM which became a unicorn in 2025, 1 years before MIG Fonds first invested in it.Here is a list of unicorns in MIG Fonds' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
76 | Developer of superconducting quantum computers | 2018 | Espoo | Series B | hysvyar |
IPOs and Publicly Listed companies in MIG Fonds' Portfolio
3 of MIG Fonds' portfolio companies have become public. Immatics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2020 and BioNTech got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), Frankfurt Stock Exchange (FRA) at marketcap of undefined.Here are MIG Fonds' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 02, 2020 | Sep 21, 2010 | Series C | 4302 | |
Oct 11, 2019 | 2008 | Seed | 4736 | |
May 31, 2018 | Nov 29, 2010 | Series A | 2234 |
Acquired companies in MIG Fonds' Portfolio
6 companies from MIG Fonds' portfolio have been acquired. The most recent acquisition was Wealthpilot in Dec 2025 by Finaplus for $*****.Here are MIG Fonds' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 04, 2025 | 2019 | Seed | 9650 | |
Jun 03, 2025 | Jun 23, 2006 | Series A | 4385 | |
Aug 22, 2024 | Feb 08, 2023 | Series D | 9147 | |
Jun 28, 2022 | May 13, 2019 | Series C | 1577 | |
Mar 19, 2019 | Sep 07, 2010 | Series D | 7975 |
Team profile of MIG Fonds
MIG Fonds has a team of 1 member located in Germany. MIG Fonds' team does not sit on the board of any company as of now.Co-investors of MIG Fonds
Over the past 21 years, 97 investors have co-invested in MIG Fonds's portfolio companies. This includes funds and angels.
- Invested before MIG Fonds: Kfw, Wellington Partners Venture Capital and 18 others have invested in rounds before MIG Fonds. There are 3 companies where Kfw has invested before MIG Fonds and 1 company where Wellington Partners Venture Capital has invested before MIG Fonds.
- Top Co-investors of MIG Fonds: 27 investors entered a company along with MIG Fonds. These include investors like BayBG (2 companies).
- Invested after MIG Fonds: A total of 50 investors have invested in MIG Fonds's portfolio after their investments. Top Investors include Europa (4 companies), MIG Capital (4 companies) and European Investment Bank (2 companies).
Recent News related to MIG Fonds
•
Bayerische invests in the MIG fund portfolio company NovemberPresseBox•Aug 31, 2023•MIG Fonds, Diebayerische
•
LyondellBasell and KIRKBI invest in APK to develop recycling technologyCNW•Feb 08, 2023•LyondellBasell, KIRKBI A/S, APK, MIG Capital and 2 others
•
European Quantum Computing Leader IQM Raises €128m Led by World Fund to Help Combat the Climate CrisisBusiness Wire India•Jul 23, 2022•IQM, World Fund, Bayern Kapital, European Innovation Council and 19 others
•
MIG Fonds invests in German Bionic SystemsPrivate Equity Wire•Dec 15, 2020•MIG Fonds, German Bionic System, Samsung Catalyst Fund, Storm Ventures and 1 other
•
•
IQM raises €39m for race to bag best quantum brains Sifted•Nov 10, 2020•IQM, Tencent, MIG Fonds, VSquared Ventures and 7 others
•
•
BayBG and MIG invest in skin cancer diagnosis specialistsVenture Capital magazine•Mar 05, 2020•MelaGenix, MIG Fonds, BayBG
•
German fintech startup wealthpilot raises €8 million for wealth management platformTech.eu•Jan 14, 2020•Wealthpilot, Seventure Partners, Bayern Kapital, MIG Fonds and 1 other
•
Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck.Life-Sciences-Germany•Sep 12, 2019•Biocrates, MIG Fonds, GAF
